Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LM11A-31-BHS in mild to moderate probable Alzheimer's disease
2015-005263-16Phase 2Completed
- Sponsor
- PharmatrophiX, Inc.
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LM11A-31 in Alzheimer's disease (AD), sponsored by PharmatrophiX, Inc.. Started May 2016; status: completed.
02
Drugs
LM11A-31
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2015-005263-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005263-16.